BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning

This publication has 22 references indexed in Scilit:

• High levels of BAX, low levels of MRP-1, and high platelets are independent predictors of response to imatinib in myeloid blast crisis of CML
  Blood, 2003
• Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases
  Blood, 2003
• Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation
  Blood, 2003
• High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML)
  Leukemia, 2002
• Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation
  Blood, 2001
• Detection and quantification of residual disease in chronic myelogenous leukemia
  Leukemia, 2000
• Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a ‘real time’ quantitative RT-PCR assay
  Leukemia, 1999
• Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real‐time quantitative RT‐PCR
  British Journal of Haematology, 1998
• Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft‐versus‐host disease and relapse
  British Journal of Haematology, 1993
• Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia
  New England Journal of Medicine, 1986